Luis Querol
Neurology — Hospital de Sant Pau, Spain
Luis Querol
LeadR Profile
Neurology
Subspecialties: Immunology - Hematology - Psychiatry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2008 - 2026
Number : 235
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort. dementia, neuroimaging, genetics, alzheimer disease, translational research, biomedical, cohort studies, biomarkers, amyotrophic lateral sclerosis, precision medicine, neuropathology, frontotemporal lobar degeneration | Alzheimers Dement | 2026 | 0 |
| Biological and clinical stability after switching from intravenous to subcutaneous natalizumab in RRMS under standard and extended dosing. natalizumab, lymphocytes, administration, intravenous, immune system diseases, lymphocyte subsets | Front Immunol | 2026 | 0 |
| Long-Term Safety and Efficacy of Efgartigimod PH20 in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: ADHERE/ADHERE+ Trial Interim Analysis. safety, incidence, polyradiculoneuropathy, chronic inflammatory demyelinating, polyradiculoneuropathy, therapeutics | J Peripher Nerv Syst | 2026 | 1 |
| Development and Inter-Laboratory Validation of Multiplex Flow Cytometry Assay for Autoimmune Nodopathy. cells, research design, flow cytometry, autoantibodies, laboratories, antibodies, enzyme-linked immunosorbent assay | J Peripher Nerv Syst | 2026 | 0 |
| Proteomic analysis reveals divergent inflammatory mechanisms of COVID-associated Guillain-Barré syndrome. cytokines, cells, sural nerve, serum, biopsy, biomarkers, guillain-barre syndrome | J Mol Med (Berl) | 2026 | 0 |
Clinical Studies 13
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 8
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Efficacy and safety of remibrutinib compared to teriflunomide in participants with relapsing multiple sclerosis followed by long term treatment with remibrutinib 2023-509372-41-00 — sclerosis, multiple sclerosis, safety, therapeutics | Phase 3 | Active not recruiting | 2022 |
| A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) 2024-517529-26-00 — safety, polyneuropathies | Phase 3 | Recruiting | 2025 |
| A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV Positive Women After Vaccination With 9vHPV (RIFT HPV) NCT05334706 — cells, antibody formation, marketing, condylomata acuminata, conservative treatment, vaccines, virion, suspensions, antibodies, squamous intraepithelial lesions of the cervix, uterine cervical neoplasms, neoplasms, enzyme-linked immunosorbent assay, vaccines, virus-like particle, human papillomavirus 16, microscopy, electron, vaccination, aged, microscopy, capsid, squamous intraepithelial lesions, human papillomavirus dna tests, viruses, warts, immunoassay, vulva, keratinocytes, therapeutics, alphapapillomavirus, hacat cells, mucous membrane, wounds and injuries, cell culture techniques, dna, papillomavirus infections, vagina, infections, cervix uteri, human papillomavirus viruses, women | Phase 4 | Recruiting | 2022 |
LeadR Networks
Main global connection map